Hermine I Brunner Selected Research

Juvenile Arthritis (Juvenile Idiopathic Arthritis)

1/2022	Children With Enthesitis-Related Arthritis and Possible Benefits From Treatments for Adults With Spondyloarthritis.
1/2022	Tofacitinib for juvenile idiopathic arthritis - Authors' reply.
1/2022	Prevention of disease flares by risk-adapted stratification of therapy withdrawal in juvenile idiopathic arthritis: results from the PREVENT-JIA trial.
11/2021	Tofacitinib in juvenile idiopathic arthritis: a double-blind, placebo-controlled, withdrawal phase 3 randomised trial.
10/2021	Subcutaneous dosing regimens of tocilizumab in children with systemic or polyarticular juvenile idiopathic arthritis.
10/2021	Open-label phase 3 study of intravenous golimumab in patients with polyarticular juvenile idiopathic arthritis.
1/2021	Functional Ability and Health-Related Quality of Life in Randomized Controlled Trials of Tocilizumab in Patients With Juvenile Idiopathic Arthritis.
1/2021	Absence of Association Between Abatacept Exposure and Initial Infection in Patients With Juvenile Idiopathic Arthritis.
1/2021	Efficacy and Safety of Tocilizumab for Polyarticular-Course Juvenile Idiopathic Arthritis in the Open-Label Two-Year Extension of a Phase III Trial.
12/2020	Abatacept: A Review of the Treatment of Polyarticular-Course Juvenile Idiopathic Arthritis.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Hermine I Brunner Research Topics

Disease

46	Juvenile Arthritis (Juvenile Idiopathic Arthritis) 01/2022 - 02/2002
30	Systemic Lupus Erythematosus (Libman-Sacks Disease) 01/2022 - 06/2003
15	Lupus Nephritis 01/2022 - 03/2004
11	Infections 11/2021 - 12/2009
6	Autoimmune Diseases (Autoimmune Disease) 01/2021 - 01/2011
6	Body Weight (Weight, Body) 01/2021 - 12/2012
5	Arthritis (Polyarthritis) 11/2021 - 12/2012
5	Macrophage Activation Syndrome 11/2019 - 03/2007
4	Fever (Fevers) 12/2020 - 12/2012
3	Neoplasms (Cancer) 01/2021 - 07/2005
3	Proteinuria 01/2021 - 03/2004
3	Rheumatic Diseases (Rheumatism) 12/2020 - 12/2015
3	Nephritis 12/2007 - 03/2004
2	Rheumatoid Arthritis 10/2021 - 06/2015
2	Pain (Aches) 01/2021 - 03/2009
2	Uveitis 06/2020 - 12/2015
2	Neutropenia 01/2019 - 12/2012
2	Hypertension (High Blood Pressure) 03/2004 - 02/2002
1	Drug-Related Side Effects and Adverse Reactions 01/2022
1	Inflammation (Inflammations) 01/2022
1	Negative rheumatoid factor polyarthritis 11/2021
1	Multiple Sclerosis 01/2021
1	Psoriatic Arthritis 12/2020
1	Glomerulonephritis 06/2020
1	Sjogren's Syndrome (Sjogren Syndrome) 06/2020
1	Tetanus 02/2020
1	Diphtheria 02/2020
1	Acquired Immunodeficiency Syndrome (AIDS) 01/2020
1	Macular Degeneration (Age-Related Maculopathy) 01/2019
1	Cardiovascular Diseases (Cardiovascular Disease) 01/2019
1	Myocardial Infarction 01/2019
1	Injection Site Reaction 01/2018
1	Lung Diseases (Lung Disease) 11/2017
1	Inclusion Body Myositis 11/2017
1	Atherosclerosis 03/2014

Drug/Important Bio-Agent (IBA)

15	Biomarkers (Surrogate Marker)IBA 01/2022 - 08/2006
9	tocilizumab (atlizumab)FDA Link 10/2021 - 12/2012
9	Methotrexate (Mexate)FDA LinkGeneric 01/2021 - 12/2009
9	Proteins (Proteins, Gene)FDA Link 01/2020 - 07/2005
6	Biological ProductsIBA 01/2022 - 03/2009
6	C-Reactive ProteinIBA 01/2022 - 12/2012
5	Antirheumatic Agents (DMARD)IBA 01/2022 - 01/2020
5	GlucocorticoidsIBA 01/2021 - 12/2012
5	canakinumab FDA Link 12/2020 - 12/2012
5	Mycophenolic Acid (Cellcept)FDA LinkGeneric 01/2020 - 01/2011
5	CreatinineIBA 01/2019 - 08/2006
4	S100A12 ProteinIBA 01/2022 - 10/2017
4	Pharmaceutical PreparationsIBA 01/2022 - 12/2009
4	Rheumatoid FactorIBA 11/2021 - 06/2012
4	CytokinesIBA 01/2021 - 02/2002
4	Abatacept (Orencia)FDA Link 01/2021 - 01/2018
3	tofacitinibIBA 01/2022 - 12/2017
3	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2022 - 02/2002
3	chlorotriphenylsilane (CTPS)IBA 01/2019 - 03/2012
3	Lipocalin-2IBA 09/2009 - 08/2006
2	SteroidsIBA 01/2022 - 08/2013
2	golimumab FDA Link 10/2021 - 01/2018
2	belimumabIBA 01/2021 - 10/2020
2	Adalimumab (Humira)FDA Link 10/2020 - 01/2020
2	VaccinesIBA 02/2020 - 01/2020
2	S100 Proteins (S 100 Protein)IBA 01/2020 - 10/2017
2	Immunosuppressive Agents (Immunosuppressants)IBA 10/2019 - 01/2011
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2019 - 01/2018
2	Hydroxychloroquine (Plaquenil)FDA LinkGeneric 01/2019 - 01/2012
2	AutoantibodiesIBA 12/2015 - 01/2015
2	Antinuclear AntibodiesIBA 12/2015 - 05/2012
2	Prednisone (Sone)FDA LinkGeneric 10/2011 - 05/2009
2	ImmunosorbentsIBA 03/2008 - 03/2007
2	EnzymesIBA 03/2008 - 03/2007
1	ixekizumabIBA 01/2022
1	secukinumabIBA 01/2022
1	Certolizumab Pegol FDA Link 01/2022
1	Estrogens (Estrogen)FDA Link 01/2021
1	ametantrone (HAQ)IBA 01/2021
1	Daclizumab (Zenapax)FDA Link 01/2021
1	ORALIT (ORS)IBA 06/2020
1	Diphtheria-Tetanus VaccineIBA 02/2020
1	Interleukin-18 (Interleukin 18)IBA 11/2019
1	OsteopontinIBA 01/2019
1	AdiponectinIBA 01/2019
1	Antimalarials (Antimalarial Agents)IBA 01/2019
1	TabletsIBA 12/2017
1	SolutionsIBA 12/2017
1	MicroRNAs (MicroRNA)IBA 01/2016
1	Circulating MicroRNAIBA 01/2016
1	Interleukin-6 (Interleukin 6)IBA 01/2016
1	AntigensIBA 12/2015
1	AntibodiesIBA 12/2015
1	Interleukin-6 Receptors (Interleukin 6 Receptor)IBA 06/2015
1	Triptorelin Pamoate (Trelstar)FDA Link 05/2015
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 05/2015
1	oxidized low density lipoproteinIBA 03/2014

Therapy/Procedure

27	Therapeutics 01/2022 - 09/2005
2	Ambulatory Care (Outpatient Care) 01/2012 - 06/2003
1	Drug Therapy (Chemotherapy) 01/2022
1	Drug Tapering 12/2020
1	Biological Therapy 11/2019
1	Replacement Arthroplasty 01/2019
1	Injections 01/2018
1	Polypharmacy 11/2017